These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of pirenzepine (Gastrozepin) on skeletal muscle contractility.
    Author: Ojewole JA.
    Journal: Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):619-23. PubMed ID: 6689440.
    Abstract:
    The effects of pirenzepine (Gastrozepin), a new anti-ulcer drug, on skeletal muscle contractility and on neuromuscular transmission have been examined in some experimental models in vitro and in vivo. Pirenzepine (5-500 micrograms/ml) inhibited agonist-(acetylcholine-, carbachol- or nicotine-) induced contractions of the toad isolated rectus abdominis muscle, and depressed electrically provoked twitches of the rat phrenic nerve-hemidiaphragm muscle preparation in vitro. Pirenzepine (5-25 mg/kg i.v.) also depressed indirect electrical stimulation-evoked twitches of the cat tibialis anterior and soleus muscle preparations in vivo. The neuromuscular blockade elicited by the anti-ulcer drug was not reversed by physostigmine, which reversed the depressant effects of d-tubocurarine on the electrically induced muscle twitches. Pirenzepine potentiated the depressant effects of d-tubocurarine on electrically evoked twitches of all skeletal muscles examined, and caused 'recurarisation' of partially curarised muscles. While the clinical significance of the neuromuscular blockade produced by the anti-ulcer agent is highlighted, it is concluded that the mechanism of skeletal muscle paralysing action of pirenzepine still remains speculative.
    [Abstract] [Full Text] [Related] [New Search]